The Role of Prolotherapy in Fibromyalgia Patients
Nirvana Mohamed Ahmed;
Abstract
Abstract
Objectives: To assess the potential role of prolotherapy in treating the most tender points of FM patients as a trial to improve symptoms.
Patients and methods: 20 primary FM Patients were injected with 3 cc of 25 % dextrose with 2 cc of 1 % lidocaine and then filled to 6 cc total volume with saline, making dextrose concentration of 12.5%, with 0.5 ml of the solution prepared per point,with a maximum of 6 points/ session. - Follow up visit were required every two weeks for other injections over a course of six weeks (duration of healing cascade). After 6 weeks, patients were assessed using NRS, FIQ VAS , MFI - 20 , SQS and PHQ-9 scales.
Objectives: To assess the potential role of prolotherapy in treating the most tender points of FM patients as a trial to improve symptoms.
Patients and methods: 20 primary FM Patients were injected with 3 cc of 25 % dextrose with 2 cc of 1 % lidocaine and then filled to 6 cc total volume with saline, making dextrose concentration of 12.5%, with 0.5 ml of the solution prepared per point,with a maximum of 6 points/ session. - Follow up visit were required every two weeks for other injections over a course of six weeks (duration of healing cascade). After 6 weeks, patients were assessed using NRS, FIQ VAS , MFI - 20 , SQS and PHQ-9 scales.
Other data
| Title | The Role of Prolotherapy in Fibromyalgia Patients | Other Titles | دور البرولوثربى فى مرضى الالتهاب العضلى الليفى | Authors | Nirvana Mohamed Ahmed | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.